Specification of transplantable astroglial subtypes from human pluripotent stem cells.

PubWeight™: 2.07‹?› | Rank: Top 2%

🔗 View Article (PMC 3111840)

Published in Nat Biotechnol on May 22, 2011

Authors

Robert Krencik1, Jason P Weick, Yan Liu, Zhi-Jian Zhang, Su-Chun Zhang

Author Affiliations

1: Neuroscience Training Program, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Articles citing this

(truncated to the top 100)

Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell (2013) 2.51

Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci (2013) 2.45

Astrocytes and disease: a neurodevelopmental perspective. Genes Dev (2012) 2.28

Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods (2015) 1.82

Dysregulation of astrocyte extracellular signaling in Costello syndrome. Sci Transl Med (2015) 1.54

Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A (2013) 1.49

Specification of neuronal and glial subtypes from human pluripotent stem cells. Cell Mol Life Sci (2011) 1.40

Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell (2014) 1.39

Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat Biotechnol (2013) 1.38

Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31

Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat Protoc (2011) 1.20

Human induced pluripotent stem cell-derived models to investigate human cytomegalovirus infection in neural cells. PLoS One (2012) 1.11

Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet (2014) 1.10

Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09

The blood-brain barrier: an engineering perspective. Front Neuroeng (2013) 1.09

Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci U S A (2016) 1.08

Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms. Cell Death Differ (2011) 1.06

Evolving concepts of gliogenesis: a look way back and ahead to the next 25 years. Neuron (2013) 1.00

High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology. Stem Cell Reports (2013) 0.99

Direct conversion of fibroblasts into functional astrocytes by defined transcription factors. Stem Cell Reports (2014) 0.99

Astrocyte development and heterogeneity. Cold Spring Harb Perspect Biol (2014) 0.99

Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep (2013) 0.98

hESC-derived Olig2+ progenitors generate a subtype of astroglia with protective effects against ischaemic brain injury. Nat Commun (2013) 0.97

Efficient specification of interneurons from human pluripotent stem cells by dorsoventral and rostrocaudal modulation. Stem Cells (2014) 0.97

GFAP expression as an indicator of disease severity in mouse models of Alexander disease. ASN Neuro (2013) 0.96

Human-induced pluripotent stem cells: potential for neurodegenerative diseases. Hum Mol Genet (2014) 0.96

Let-7 and miR-125 cooperate to prime progenitors for astrogliogenesis. EMBO J (2015) 0.95

Modeling Huntington's disease with induced pluripotent stem cells. Mol Cell Neurosci (2013) 0.94

A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia. J Neurosci (2014) 0.93

Caudalized human iPSC-derived neural progenitor cells produce neurons and glia but fail to restore function in an early chronic spinal cord injury model. Exp Neurol (2013) 0.93

Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells. J Neurogenet (2014) 0.91

Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. J Virol (2014) 0.91

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci (2016) 0.90

Stimulation of GABA-induced Ca2+ influx enhances maturation of human induced pluripotent stem cell-derived neurons. PLoS One (2013) 0.90

Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet (2013) 0.89

Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm. Stem Cell Reports (2015) 0.89

Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS (2013) 0.86

Human-derived neural progenitors functionally replace astrocytes in adult mice. J Clin Invest (2015) 0.86

Endogenous proliferation after spinal cord injury in animal models. Stem Cells Int (2012) 0.85

Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity. J Huntingtons Dis (2016) 0.85

Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. Cell Stem Cell (2015) 0.85

Experimental and therapeutic opportunities for stem cells in multiple sclerosis. Int J Mol Sci (2012) 0.84

Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci (2016) 0.84

Converted neural cells: induced to a cure? Protein Cell (2012) 0.83

Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders. Stem Cell Reports (2015) 0.83

Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Transl Med (2014) 0.82

Human stem cell-derived astrocytes and their application to studying Nrf2-mediated neuroprotective pathways and therapeutics in neurodegeneration. Br J Clin Pharmacol (2013) 0.82

NMDA receptor-dependent glutamate excitotoxicity in human embryonic stem cell-derived neurons. Neurosci Lett (2013) 0.82

The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology (2012) 0.82

Three dimensional cellular microarray platform for human neural stem cell differentiation and toxicology. Stem Cell Res (2014) 0.81

How to make an oligodendrocyte. Development (2015) 0.81

Glia: an emerging target for neurological disease therapy. Stem Cell Res Ther (2012) 0.81

Toward stem cell-based phenotypic screens for neurodegenerative diseases. Nat Rev Neurol (2015) 0.81

Therapeutically targeting astrocytes with stem and progenitor cell transplantation following traumatic spinal cord injury. Brain Res (2014) 0.81

A cellular star atlas: using astrocytes from human pluripotent stem cells for disease studies. Front Cell Neurosci (2013) 0.81

Stem and Progenitor Cell-Derived Astroglia Therapies for Neurological Diseases. Trends Mol Med (2015) 0.81

Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells (2015) 0.80

Human iPSC-Derived Immature Astroglia Promote Oligodendrogenesis by Increasing TIMP-1 Secretion. Cell Rep (2016) 0.80

The potential of iPS cells in synucleinopathy research. Stem Cells Int (2012) 0.80

Stem cells as a potential therapy for epilepsy. Exp Neurol (2012) 0.80

Biomedical and clinical promises of human pluripotent stem cells for neurological disorders. Biomed Res Int (2013) 0.80

Human pluripotent stem cell-derived radial glia recapitulate developmental events and provide real-time access to cortical neurons and astrocytes. Stem Cells Transl Med (2015) 0.79

An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells. Stem Cell Reports (2017) 0.79

Specification of functional neurons and glia from human pluripotent stem cells. Protein Cell (2012) 0.79

Matrix-specified differentiation of human decidua parietalis placental stem cells. Biochem Biophys Res Commun (2013) 0.79

The State of Play with iPSCs and Spinal Cord Injury Models. J Clin Med (2015) 0.79

Generation of GFAP::GFP astrocyte reporter lines from human adult fibroblast-derived iPS cells using zinc-finger nuclease technology. Glia (2015) 0.79

Neurosphere Based Differentiation of Human iPSC Improves Astrocyte Differentiation. Stem Cells Int (2015) 0.79

Common pitfalls of stem cell differentiation: a guide to improving protocols for neurodegenerative disease models and research. Cell Mol Life Sci (2016) 0.78

A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther (2013) 0.78

Probing the secrets of Alzheimer's disease using human-induced pluripotent stem cell technology. Neurotherapeutics (2015) 0.78

Glia: guardians, gluttons, or guides for the maintenance of neuronal connectivity? Ann N Y Acad Sci (2015) 0.78

Human pluripotent stem cell models of Fragile X syndrome. Mol Cell Neurosci (2015) 0.77

Human glial progenitor engraftment and gene expression is independent of the ALS environment. Exp Neurol (2014) 0.77

Rapid and robust generation of long-term self-renewing human neural stem cells with the ability to generate mature astroglia. Sci Rep (2015) 0.77

Differentiation of human fetal multipotential neural progenitor cells to astrocytes reveals susceptibility factors for JC virus. J Virol (2013) 0.77

Efficient generation of region-specific forebrain neurons from human pluripotent stem cells under highly defined condition. Sci Rep (2015) 0.77

Neural Subtype Specification from Human Pluripotent Stem Cells. Cell Stem Cell (2016) 0.76

Engineering human cells and tissues through pluripotent stem cells. Curr Opin Biotechnol (2016) 0.76

Stem cell-derived astrocytes: are they physiologically credible? J Physiol (2016) 0.76

Sensory Response of Transplanted Astrocytes in Adult Mammalian Cortex In Vivo. Cereb Cortex (2016) 0.76

Human astrocytes are distinct contributors to the complexity of synaptic function. Brain Res Bull (2016) 0.75

Building blocks of the cerebral cortex: from development to the dish. Wiley Interdiscip Rev Dev Biol (2015) 0.75

New approaches for direct conversion of patient fibroblasts into neural cells. Brain Res (2015) 0.75

Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Sci Rep (2016) 0.75

Species-specific developmental timing is maintained by pluripotent stem cells ex utero. Dev Biol (2017) 0.75

Phenotypic screening with primary neurons to identify drug targets for regeneration and degeneration. Mol Cell Neurosci (2016) 0.75

Parkinson's Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson's Disease, If Anything? Stem Cells Int (2012) 0.75

An update on stem cell biology and engineering for brain development. Mol Psychiatry (2017) 0.75

Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases. Annu Rev Pharmacol Toxicol (2015) 0.75

Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease. Psychiatry Investig (2016) 0.75

Physiological, pathological, and engineered cell identity reprogramming in the central nervous system. Wiley Interdiscip Rev Dev Biol (2016) 0.75

Astrocyte-like cells differentiated from a novel population of CD45-positive cells in adult human peripheral blood. Cell Biol Int (2014) 0.75

Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Reports (2017) 0.75

Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders. Curr Stem Cell Rep (2016) 0.75

Humanized neuronal chimeric mouse brain generated by neonatally engrafted human iPSC-derived primitive neural progenitor cells. JCI Insight (2016) 0.75

Time-Course Gene Expression Profiling Reveals a Novel Role of Non-Canonical WNT Signaling During Neural Induction. Sci Rep (2016) 0.75

Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish. Brain Res (2016) 0.75

Astrocyte Differentiation of Human Pluripotent Stem Cells: New Tools for Neurological Disorder Research. Front Cell Neurosci (2016) 0.75

Human neural progenitors derived from integration-free iPSCs for SCI therapy. Stem Cell Res (2017) 0.75

Articles cited by this

Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50

A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci (2008) 17.27

Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell (2005) 7.41

Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A (2010) 7.31

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron (1996) 7.20

Glial regulation of the cerebral microvasculature. Nat Neurosci (2007) 5.91

Control of synapse number by glia. Science (2001) 5.38

The mystery and magic of glia: a perspective on their roles in health and disease. Neuron (2008) 5.32

Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet (2001) 4.63

Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells (2007) 3.71

Uniquely hominid features of adult human astrocytes. J Neurosci (2009) 3.49

Astroglial metabolic networks sustain hippocampal synaptic transmission. Science (2008) 3.49

Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci (2007) 3.25

Retinoic acid in development: towards an integrated view. Nat Rev Genet (2008) 3.24

Signaling at the gliovascular interface. J Neurosci (2003) 3.16

Area patterning of the mammalian cortex. Neuron (2007) 3.12

Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci (2007) 3.02

Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci (2006) 2.76

Glial specification in the vertebrate neural tube. Nat Rev Neurosci (2004) 2.75

Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci (2008) 2.67

Developmental genetics of vertebrate glial-cell specification. Nature (2010) 2.44

Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development (2009) 2.23

The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord. Neuron (2006) 2.18

Astrocyte calcium waves: what they are and what they do. Glia (2006) 2.17

Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc (2009) 2.11

Loss of astrocytic domain organization in the epileptic brain. J Neurosci (2008) 1.92

Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell (2008) 1.79

Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci U S A (2004) 1.76

Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol (2001) 1.70

CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol (2004) 1.66

Specification of astrocytes by bHLH protein SCL in a restricted region of the neural tube. Nature (2005) 1.62

Combinatorial actions of patterning and HLH transcription factors in the spatiotemporal control of neurogenesis and gliogenesis in the developing spinal cord. Development (2007) 1.55

Development of GLAST(+) astrocytes and NG2(+) glia in rat hippocampus CA1: mature astrocytes are electrophysiologically passive. J Neurophysiol (2005) 1.54

Defining glial cells during CNS development. Nat Rev Neurosci (2001) 1.50

Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation. Glia (2009) 1.46

Neuroglia: the 150 years after. Trends Neurosci (2008) 1.31

Astrocytes and NG2-glia: what's in a name? J Anat (2005) 1.25

Specification of CNS glia from neural stem cells in the embryonic neuroepithelium. Philos Trans R Soc Lond B Biol Sci (2008) 1.21

Extent of intercellular calcium wave propagation is related to gap junction permeability and level of connexin-43 expression in astrocytes in primary cultures from four brain regions. Neuroscience (1999) 1.20

Activity-dependent ATP-waves in the mouse neocortex are independent from astrocytic calcium waves. Cereb Cortex (2005) 1.20

Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system. J Neurochem (2009) 1.12

Human embryonic stem cell-derived neural precursors develop into neurons and integrate into the host brain. J Neurosci Res (2006) 1.10

GABA uptake-dependent Ca(2+) signaling in developing olfactory bulb astrocytes. Proc Natl Acad Sci U S A (2009) 1.08

Common astrocytic programs during brain development, injury and cancer. Trends Neurosci (2009) 1.01

Glial and neuronal differentiation in the human fetal brain 9-23 weeks of gestation. Neuropathol Appl Neurobiol (1990) 0.93

Evaluation of L-glutamate clearance capacity of cultured rat cortical astrocytes. Biol Pharm Bull (2000) 0.89

Hyperpolarization-activated ion currents in cultured rat cortical and spinal cord astrocytes. Glia (1996) 0.89

Tubulin and glial fibrillary acidic protein gene expression in developing fetal human brain at midgestation. Neurochem Res (1999) 0.82

Articles by these authors

Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med (2008) 8.03

Specification of motoneurons from human embryonic stem cells. Nat Biotechnol (2005) 7.74

Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A (2010) 7.31

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature (2012) 7.01

A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science (2011) 5.44

The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat Genet (2006) 5.36

Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA (2008) 5.01

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet (2006) 4.22

Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study. Lancet (2005) 4.15

New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst (2006) 3.90

Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet (2010) 3.89

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer (2007) 3.77

Directed neural differentiation of human embryonic stem cells via an obligated primitive anterior stage. Stem Cells (2007) 3.71

Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A (2009) 3.53

FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell (2007) 3.46

Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells (2005) 3.38

Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A (2012) 3.33

Nucleus accumbens dopamine differentially mediates the formation and maintenance of monogamous pair bonds. Nat Neurosci (2005) 3.29

Functional neural development from human embryonic stem cells: accelerated synaptic activity via astrocyte coculture. J Neurosci (2007) 3.25

A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature (2012) 3.24

Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol (2008) 3.23

Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol (2008) 3.22

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell (2013) 3.13

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol (2013) 3.11

DNA origami with complex curvatures in three-dimensional space. Science (2011) 3.08

Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol (2009) 3.07

Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol (2009) 2.91

Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell (2011) 2.80

Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2005) 2.76

Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study. J Clin Oncol (2006) 2.71

Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study. Cancer (2002) 2.70

A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med (2005) 2.66

The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α. Nat Med (2012) 2.66

Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell (2012) 2.62

Self-assembled water-soluble nucleic acid probe tiles for label-free RNA hybridization assays. Science (2008) 2.60

Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57

Estradiol activates group I and II metabotropic glutamate receptor signaling, leading to opposing influences on cAMP response element-binding protein. J Neurosci (2005) 2.54

Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells (2008) 2.54

Insights into colon cancer etiology via a regularized approach to gene set analysis of GWAS data. Am J Hum Genet (2010) 2.50

A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst (2002) 2.49

Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell (2010) 2.46

Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med (2011) 2.45

Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35

Phase diagram and electronic indication of high-temperature superconductivity at 65 K in single-layer FeSe films. Nat Mater (2013) 2.34

Control of self-assembly of DNA tubules through integration of gold nanoparticles. Science (2009) 2.31

A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol (2003) 2.30

Transgenes delivered by lentiviral vector are suppressed in human embryonic stem cells in a promoter-dependent manner. Stem Cells Dev (2007) 2.27

Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev (2003) 2.26

Associations between diet, lifestyle factors, and telomere length in women. Am J Clin Nutr (2010) 2.23

Coordination of sonic hedgehog and Wnt signaling determines ventral and dorsal telencephalic neuron types from human embryonic stem cells. Development (2009) 2.23

Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells (2007) 2.22

Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma. Am J Gastroenterol (2010) 2.20

Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles. Nat Neurosci (2013) 2.20

Self-assembled DNA nanostructures for distance-dependent multivalent ligand-protein binding. Nat Nanotechnol (2008) 2.19

Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol (2002) 2.15

An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice. J Clin Invest (2012) 2.13

Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J Exp Med (2012) 2.12

Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc (2009) 2.11

Effects of Panax notoginseng saponins on the activities of CYP1A2, CYP2C9, CYP2D6 and CYP3A4 in rats in vivo. Phytother Res (2011) 2.11

The zebrafish fleer gene encodes an essential regulator of cilia tubulin polyglutamylation. Mol Biol Cell (2007) 2.05

A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev (2003) 2.04

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood (2005) 2.04

Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med (2014) 2.01

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis (2006) 2.00

Novel clinical and molecular findings in Chinese families with dyschromatosis symmetrica hereditaria. J Dermatol (2011) 1.99

Human TH17 cells are long-lived effector memory cells. Sci Transl Med (2011) 1.99

CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms. Nat Genet (2012) 1.99

Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish. Neuron (2007) 1.96

Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) (2010) 1.95

IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat Immunol (2011) 1.94

Malectin: a novel carbohydrate-binding protein of the endoplasmic reticulum and a candidate player in the early steps of protein N-glycosylation. Mol Biol Cell (2008) 1.94

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activity. Cancer Res (2007) 1.91

Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. Am J Hum Genet (2013) 1.90

Human oligodendrocytes from embryonic stem cells: conserved SHH signaling networks and divergent FGF effects. Development (2009) 1.90

Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy. Am J Physiol Heart Circ Physiol (2009) 1.90

The transcription factor WIN1/SHN1 regulates Cutin biosynthesis in Arabidopsis thaliana. Plant Cell (2007) 1.88

Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzyme. Structure (2003) 1.84

Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc (2009) 1.83

The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell (2006) 1.83

Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res (2009) 1.83

Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D. Infect Immun (2009) 1.83

Periodic square-like gold nanoparticle arrays templated by self-assembled 2D DNA Nanogrids on a surface. Nano Lett (2006) 1.81

Fit for Life Boy Scout badge: outcome evaluation of a troop and Internet intervention. Prev Med (2006) 1.80

New insights into the mechanisms of vitamin D action. J Cell Biochem (2003) 1.79

A critical role for nucleus accumbens dopamine in partner-preference formation in male prairie voles. J Neurosci (2003) 1.78

Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice. Nat Genet (2006) 1.77

FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest (2007) 1.76

Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea. J Korean Med Sci (2009) 1.75

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer (2009) 1.74

Kinematic state estimation and motion planning for stochastic nonholonomic systems using the exponential map. Robotica (2008) 1.74

Multilayer DNA origami packed on a square lattice. J Am Chem Soc (2009) 1.74

Scaffolded DNA origami of a DNA tetrahedron molecular container. Nano Lett (2009) 1.71

Height, predictors of C-peptide and cancer risk in men. Int J Epidemiol (2004) 1.69

Health insurance coverage in survivors of childhood cancer: the Childhood Cancer Survivor Study. J Clin Oncol (2005) 1.69